We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Spinal Tap Needle Impacts Risk of Complications

By LabMedica International staff writers
Posted on 20 Dec 2017
Print article
Image: Aspects of the two needles used in lumbar puncture: Upper: Atraumatic needle that reduces complications; lower: conventional needle cuts the dura (Photo courtesy of Southern General Hospital).
Image: Aspects of the two needles used in lumbar puncture: Upper: Atraumatic needle that reduces complications; lower: conventional needle cuts the dura (Photo courtesy of Southern General Hospital).
A lumbar puncture, commonly known as a spinal tap, is a regular medical procedure used to diagnose and to treat disease. Post-dural puncture headaches appear in about 35% of patients, sometimes causing debilitating pain that can lead to a return to hospital for painkillers or more invasive treatment.

Needle tip design has been proposed to affect the incidence of headache post-lumbar puncture, with pencil-point ‘atraumatic’ needles thought to reduce its incidence in comparison to beveled ‘traumatic’ needles. Despite this, the use of atraumatic needles and knowledge of their existence remains significantly limited among clinicians.

Medical scientists at McMaster University (Hamilton, ON, Canada) searched published randomized controlled trials (RCTs), observational studies and abstracts, with no publication type or language restrictions. They examined the outcomes of: headache and its type, intensity, duration and treatment; backache; success rate; hearing disturbance and nerve root irritation. The primary outcome was the incidence of post-dural puncture headache. The study pooled data from 110 clinical trials, with more than 30,000 participants in 29 countries across the past 28 years.

The team recorded that using atraumatic needles rather than conventional traumatic needles for lumbar punctures is just as effective and results in a significant decrease in complications such as the headaches, the need for intravenous fluid or controlled analgesia, nerve root irritation and hearing disturbance. They explained that the sharp edges of the tip of a conventional needle cuts its way through, while the tip of an atraumatic needle causes the tissue to dilate and contract around it. The tiny hole left in the dura by the atraumatic needle makes it significantly more difficult for cerebrospinal fluid to leak through, thus diminishing the frequency of headaches, readmissions and treatment. They also found the atraumatic needles cost the same or up to three times as much as the more conventional type.

Saleh A. Almenawer, MD, a neurosurgeon and senior author of the study, said, “There is a more than 50% reduction in the occurrence of headaches with the atraumatic needles, and also more than a 50% reduction in patient readmissions and return to emergency rooms for narcotics or blood patches. The two needles differ in how they penetrate the thick membrane, called the dura, surrounding the nerves. This study provides convincing high-quality evidence for people to change to the atraumatic needles for a better patient care.” The study was published on December 6, 2017, in the journal The Lancet.

Related Links:
McMaster University

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.